Cargando…
Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
In the interaction between a tumor and the immune system, immune checkpoints play an important role, and in tumor immune escape, co-inhibitory immune checkpoints are important. Immune checkpoint inhibitors (ICIs) can enhance the immune system’s killing effect on tumors. To date, impressive progress...
Autores principales: | Shen, Shaoping, Chen, Ling, Liu, Jialin, Yang, Lin, Zhang, Mengna, Wang, Lingxiong, Zhang, Rong, Uemura, Yasushi, Wu, Qiyan, Yu, Xinguang, Liu, Tianyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476097/ https://www.ncbi.nlm.nih.gov/pubmed/32944390 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0027 |
Ejemplares similares
-
Analysis of human glioma-associated co-inhibitory immune checkpoints
in glioma microenvironment and peripheral blood
por: Shen, Shaoping, et al.
Publicado: (2021) -
The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma
por: Wu, Liangliang, et al.
Publicado: (2023) -
Emerging therapies for glioblastoma: current state and future directions
por: Rong, Liang, et al.
Publicado: (2022) -
Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy
por: Liu, Hongyu, et al.
Publicado: (2017) -
Glioblastoma multiforme with vertebral metastases: A case report
por: Liu, Hongyu, et al.
Publicado: (2021)